B7-H7 knockdown suppresses the proliferation, metastasis, and drug resistance of B-cell non-Hodgkin lymphoma cells by inhibiting the PI3K/Akt pathway. Here, HHLA2 is linked to B-cell non-Hodgkin lymphoma.